Liver resection versus transarterial chemoembolization for the treatment of intermediate‐stage hepatocellular carcinoma

BACKGROUND: The role of transarterial chemoembolization (TACE) as the standard treatment for intermediate‐stage hepatocellular carcinoma (HCC) is being challenged by increasing studies supporting liver resection (LR); but evidence of survival benefits of LR is lacking. We aimed to compare the overal...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shuling, Jin, Huilin, Dai, Zihao, Wei, Mengchao, Xiao, Han, Su, Tianhong, Li, Bin, Liu, Xin, Wang, Yu, Li, Jiaping, Shen, Shunli, Zhou, Qi, Peng, Baogang, Peng, Zhenwei, Peng, Sui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488138/
https://www.ncbi.nlm.nih.gov/pubmed/30864247
http://dx.doi.org/10.1002/cam4.2038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488138/
https://www.ncbi.nlm.nih.gov/pubmed/30864247
http://dx.doi.org/10.1002/cam4.2038

Ejemplares similares